LatchBio is a modern data and compute platform for biotech R&D. It is not positioned as a general-purpose AI tool, but rather as data infrastructure for biological data analysis, omics workflows, and R&D compliance. The website says it supports 40+ kits, instruments, or services, and is used by 300+ biopharmas and R&D Labs, as well as 4000+ scientists.
On the AI side, LatchBio focuses on an Agent for βbiology data analysis,β labeled as powered by Claude 4.5 Opus. In Plots/Notebook environments, it can write code from prompts, create visualizations, fix bugs, build interactive apps, and launch analysis workflows. The platform supports formats including FastQ, CSV, Excel, H5AD, and TIFF, covering use cases such as Bulk RNA-Seq, ATAC-Seq, qPCR, gene editing, spatial transcriptomics, and single-cell analysis. On the engineering side, LatchBio provides Nextflow workflow orchestration, Jupyter Labs, RStudio, cloud compute via Pods, Registry metadata management, File Storage, Plots visualization, and white-label customer analysis portals.
Pricing is usage-based: 1 Credit = USD 1. Credits never expire and can be used for Workflows, Pods, and Data Storage. The website explicitly states that there are no subscription fees, license fees, or per-seat charges. CPU, RAM, GPU, storage, and mounts are all billed based on resource usage, with an example showing Bulk RNA-Seq for 8 samples costing about 14.101 credits. Enterprise plans include volume discounts, 24/7 priority Slack support, engineering assistance, and a 7-day pilot.
Its main strength is its strong vertical focus: it bundles bioinformatics workflows, cloud resources, visualization, data import, and compliance auditing into one platform, making it suitable for teams that need reproducible analysis and customer delivery. Its security and compliance information is also fairly complete, including AES-256 encryption, AWS KMS, SOC 2 Type II, penetration testing, audit logs, and FDA/IND-related support. The limitations are that the accuracy, boundaries, and failure cases of the AI Agent are not disclosed; the learning curve is high for users without a biology background; and large-scale compute still requires cost governance.
LatchBio is best suited for biotech companies, pharmaceutical R&D teams, bioinformatics teams, computational scientists, and instrument, kit, or service providers that want to offer white-label analysis portals to customers. The main content does not specify whether there is a Chinese interface, Chinese-language support, payment options, or reliable availability from mainland China, so access from China should be considered unknown. If users in China face network, compliance, or payment restrictions, alternatives to compare include Seven Bridges, DNAnexus, Terra.bio, Benchling, Illumina BaseSpace, Galaxy, or Seqera Platform.
β This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on latch.bio official site.
latch.bio is an United States AI Apps provider. TG4G tracks its product information, an overall rating of 8.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach latch.bio directly.